Today, at WIRED’s 2017 Business Conference in New York, it took just a few minutes. Doudna said it was exactly this possibility—Crispr custom-designed human offspring—that made her take a step back from her own research and get involved in public discussions around the technology. For the last few years she’s been speaking to scientists, politicians, and federal regulators around the world about the potential risks and rewards of Crispr. “I think it’s really likely that in the not-too-distant future it will cure genetic disease,” she said. “But globally we need to come up with a consensus on moving forward in a responsible way.”
